Human Gene Editing
CRISPR co-creator Jennifer Doudna on how gene editing can tackle antibiotic resistance crisis
Understanding how CRISPR could be used to tackle antibiotic resistance, we need to understand how that resistance arises in the ...
What do Muslim leaders have to say about ethics of germline editing to prevent diseases?
Dr Sayyed Mohamed Muhsin and Dr Alexis Heng Boon Chin give ethical analysis of germline genome editing based on Islamic ...
‘People are going to be better-looking, healthier and smarter – what’s not to like?’ What are the pitfalls of selecting embryos for intelligence?
The second age of eugenics: Would you select an embryo according to its chances of higher intelligence? And is that ...
Gene therapy has restored hearing for a second child. Here’s why some deaf people adamantly oppose treatment
Children's Hospital of Philadelphia surgeon John Germiller was among the world's first to successfully treat a deaf child with gene ...
Unique use of CRISPR gene editing is paving the way to treat cancer
New gene-editing approach to studying immune gene function could improve treatments for cancer, other diseases ...
Probiotics are ‘enticing target’ for gene editing — but is CRISPR up for the challenge?
Every morning I pop a Pearl probiotic. I try hard not to drop it, for the tiny, slippery yellow sphere ...
100,000 Americans are waiting for transplants. Could pig-grown organs close this gap?
The need for more transplant organs is immense and some scientists think animal organs might be a good way to ...
Acne treatment of the future: Gene-editing the bacteria that lives on your skin
An experimental study has shown that a type of skin bacterium can efficiently be engineered to produce a protein to ...
‘There is no sound I don’t like’ — In gene editing breakthrough, Lilly’s 30-day gene therapy restores hearing of 11-year old boy, with more deafness treatments on the way
The genetic treatment targeted a particular kind of congenital deafness and will soon be tried in children who are younger ...
$3 million barrier to sickle cell gene therapy: How prohibitive costs could limit practical benefits of newly-approved drugs
In a much-anticipated move, the Federal Drug Administration (FDA) has approved two new gene therapies for sickle cell disease ...
Viewpoint: ‘Artificial intelligence poses a whole new threat to the already dangerous practice of heritable human genetic modification’
Artificial intelligence poses a whole new threat to the already dangerous practice of heritable human genetic modification ...
Viewpoint: I took the exa-cel treatment for sickle cell disease. My symptoms ‘virtually disappeared overnight’
Exa-cel, the first CRISPR-based treatment to win approval from the US Food and Drug Administration, following the UK’s approval ...
How Casgevy came to be: How researchers found gene editing targets for newly-approved sickle cell drug
The world’s first commercial gene-editing treatment is set to start changing the lives of people with sickle-cell disease ...
CRISPR moonshot: FDA approves first-ever US gene-edited based therapy, Casgevy, to treat sickle cell disease
December 8 the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene ...
CRISPR is cheap, effective and easy to use. That’s why human germline editing scares even some proponents
Crispr technology is based on a rudimentary immune system that Japanese scientists first noticed in bacteria three decades ago ...
Viewpoint: Skeptical take on newly-approved CRISPR sickle cell treatment tool
A gene editing therapy developed by Vertex Pharmaceuticals and CRISPR Therapeutics works exceptionally well, yet treatment may not be simple ...
Viewpoint: Center for Genetics and Society advances ‘progressive’, ‘techno-pessimist’ argument against human germline editing
AI is a hot topic that some experts deeply steeped in the AI debate are warning about the social justice ...
USDA under pressure to liberalize regulation of human gene-therapies and gene-editing, so US doesn’t fall further behind other countries
Worries about heritable genetic modifications are subsiding and sponsors should consider the US for regulatory advice and clinical trials ...
Experimental treatment using CRISPR to dramatically lower cholesterol under scrutiny after two patients suffer heart attacks and one dies
Researchers have been able to reduce bad cholesterol in human subjects after injecting them with an experimental gene editing treatment ...
CRISPR gene editing tackles yet another health scourge: High cholesterol
Study shows that gene-editing technology can be used to successfully treat a genetic disorder that increases the risk of heart ...
Playing God: Catholic ethical experts caution against ‘superhuman’ genetic future
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats: Ethicists fixate on this innovation creating “superhumans.” ...
First CRISPR drug: UK approves Casgevy to prevent pain from sickle cell disease and beta thalassemia
The gene-editing therapy Casgevy uses Crispr to prevent debilitating pain in patients with sickle cell disease ...
100,000 Americans, mostly Black, are victims of sickle cell anemia. CRISPR is on the cusp of treating it
Exa-cel, a new gene therapy treatment using CRISPR technology, shows promise in treating SCD by editing the patient's stem cells ...
First clinical trial of CRISPR cure for HIV is encouraging — but comes with scant details
California-based biotech company Excision BioTherapeutics has shared data from the first human clinical trial of a CRISPR cure for HIV ...
Gene therapy treatment restores hearing to five children in China. Will the results last?
After deafness treatment, Yiyi can hear her mother and dance to the music. But why is it so noisy at ...
Viewpoint: Breaking taboos or pioneering breakthroughs? Weighing ethics of gene editing of human embryos
The German Ethics Council has now also ruled that inheritable genome editing is fundamentally morally permissible ...
Breakthrough CRISPR treatment for sickle cell anemia up for FDA approval
Advisers to the US regulatory agency will examine the safety profile of a CRISPR-based treatment for sickle-cell disease ...